We detected the activation of AKT in wild-type and PAQR4-overexpressing HCC cells stimulated with or without Insulin-like growth factor-1 (IGF-1), which is regarded as an activator of the AKT pathway [29, 30]. Here, AKT1 is linked to hepatocellular carcinoma.